Actually biotech isn't fast at all, let alone very fast. Due to the nature of clinical trials. Compare that to areas in hw/sw technology, they eat their young in that arena. What biotech is, especially with market caps under $500mil, is often a high risk investment. Volatile yes, fast no.
My original comment was related to diligence, as I'm sure must understand. I'll stand by my original idea, don't put much trust in one upgrade from one analyst. That and take most of what you read in forums with a shaker of salt. If anything, when you have so many perma-bulls hoping to make it rich on single stock, do give a look to the other side of the coin.
News 
Market Data 
Discover 
